Investors

Home / Investors

Greenlight Analytical (GLA) is seeking investment funds to complete the development and release of our novel cannabis analyzer. More information can be found on Gust or contact us here

Greenlight Analytical (GLA) provides a comprehensive in-house cannabis testing technology for Licensed Producers (LPs). We have revolutionized the testing market by eliminating the time consuming, labour intensive, and error prone sample preparation required by traditional devices. We deliver accuracy & performance unheard of in any other in-house technology.

GLA provides a data driven production tool to help optimize harvest & increase revenue by offering actionable insights allowing Licensed Producers to.

  • Reduce unit cost ($/gram)
  • Maximize yield (grams/sq. ft.)
  • Maximize potency
  • Provide a consistent customer experience

The Cannabis Market

The cannabis market has changed dramatically, licensed producers (LP)’s have pivoted from growth to efficiency and need tools to optimize all facets of production. GLA’s bench-top analyzer will allow LP’s to identify the optimal point at which crops reach their maximum quality; whether that’s taste, smell, potency, or some combination thereof; testing with GLA’s analyzer will allow producers to achieve maximum throughput for their facility.  

GLA’s bench-top Chemical Analyzer, designed to be used in the grow-room, will allow producers to increase revenue by maximizing THC/CBD potency, and monitor terpenes and flavour compounds to create consistent strains for which customers will pay a premium. 

GLA’s beach-head market; Cannabis and Derivatives (edibles, drinkables, CBD wellness products); will provide early revenue through sales to LP's. The value of the cannabis/CBD industry is expected to grow to $5.2B in Canada, and globally to $92.8B, by 2027, with a CAGR of 20%. Recurring revenue will be realized through proprietary data & software licenses, service & support contracts, and leasing.

Growth Markets

Our growth markets; Healthcare and Law Enforcement; will open up an $8B opportunity. With simple software and packaging changes, our analyzers will ensure product safety and consistency, empower medical personnel with critical information to save lives, and provide government regulators and revenue enforcement agencies with tools to ensure compliance with tax and supply chain regulations.

Please use our contact page to get in touch or reach us via Gust.

These documents contain “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information is disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action. This forward-looking information is based on current expectations, estimates and assumptions concerning future events and is subject to a number of uncertainties and factors, many of which are outside the company’s control, which could cause actual results to differ materially from those described in the forward-looking information. No assurance can be given that any of the events anticipated by the forward-looking information will transpire or occur or, if any of them do so, what benefits will be derived therefrom. Shareholders, potential shareholders, financing institutions and other readers are urged to consider these factors carefully in evaluating the forward-looking information which speak only as of the date made. Except as may be required by law, the company expressly disclaims any intention or obligation to revise or update any forward-looking information and information whether as a result of new information, future events or otherwise.